Skip to content

Clinical trials

Completed Cognitive Dysfunction trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Status: Completed Country / region: Brazil Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20141
20181
20192
20201
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo4
Hospital Israelita Albert Einstein2
University of Sao Paulo General Hospital2
Federal University of Rio Grande do Sul1
Hospital Sao Domingos1
Instituto Nacional de Cardiologia de Laranjeiras1
Marcelo Demarzo, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction12
COVID-192
Dementia2
Alzheimer Disease1
Anxiety Disorders1
Atrial Fibrillation1
Cardiovascular Diseases1
Diabetes Mellitus1
Heart Diseases1
Hypertension1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.